RecruitingNot ApplicableNCT07016009

Thrive Person-Centered Planning Program for Young Adults With Fetal Alcohol Spectrum Disorders

Randomized Controlled Trial of the Thrive Person-Centered Planning Program for Young Adults With FASD


Sponsor

University of Rochester

Enrollment

60 participants

Start Date

Apr 14, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study evaluates the Thrive person centered planning program for young adults with fetal alcohol spectrum disorders. Participants are randomized to either an immediate start or delayed start group for the psychoeducation phase. Following this phase, participants are randomized again to receive the intervention in either an individual or group based format. Participants complete repeated online assessments at multiple timepoints over approximately 10 months to evaluate whether the program improves goal setting, social support, and quality of life.


Eligibility

Min Age: 18 YearsMax Age: 25 Years

Inclusion Criteria3

  • Young adult between the ages of 18 and 25
  • Lives in the United States
  • Has a diagnosis of fetal alcohol spectrum disorder or confirmed prenatal alcohol exposure

Exclusion Criteria2

  • Does not have access to the internet or data plan allowing video conferencing
  • Is not able to listen or speak in English

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALThrive Program

Thrive is a person centered planning intervention delivered in stages including identification, psychoeducation, goal setting, and implementation. The program is delivered via Zoom over approximately 12 to 15 sessions. Participants may receive the intervention immediately or after a delay and complete goal setting in either an individual format or a group format involving their social network.


Locations(1)

University of Rochester

Rochester, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07016009


Related Trials